A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)
Clinical trial NCT04282980 · COMPLETED
Trial details
- NCT number
- NCT04282980
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-23
- Primary completion
- 2021-02-26
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.